4//SEC Filing
Peterson Kristine 4
Accession 0001062993-25-005505
CIK 0001177648other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:43 PM ET
Size
8.6 KB
Accession
0001062993-25-005505
Insider Transaction Report
Form 4
Peterson Kristine
Director
Transactions
- Award
Stock Option (right to buy)
2025-03-13+15,700→ 15,700 totalExercise: $6.83Exp: 2035-03-13→ Common Stock (15,700 underlying)
Footnotes (1)
- [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 13, 2025), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2026 annual meeting of stockholders.
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001508596
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:43 PM ET
- Size
- 8.6 KB